Arterial and Plethysmographic Waveforms Variables as Predictors of Hemodynamic Response to Pneumoperitoneum (SPV-PnP)
Primary Purpose
Pneumoperitoneum, Heart Output Disorder
Status
Unknown status
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
Pneumoperitoneum
Sponsored by
About this trial
This is an interventional diagnostic trial for Pneumoperitoneum
Eligibility Criteria
Inclusion Criteria:
- The patients scheduled for elective laparoscopic partial hepatectomy, laparoscopic splenectomy, laparoscopic pancreatectomy - required of continuous direct blood pressure monitoring according to the type of surgery
- The patients ASA class III-IV scheduled for elective laparoscopic colectomy and hemicolectomy - required of continuous direct blood pressure monitoring according to their medical condition
- Pneumoperitoneum by needle application only
- Normal sinus cardiac rhythm
Exclusion Criteria:
- Patients that didn't sign informed consent
- Patients ASA class I-II scheduled for elective laparoscopic colectomy or hemicolectomy
- Patients scheduled for elective laparoscopic cholecystectomy
- Patients required of monitoring by pulmonary artery catheter during the surgery according to their medical condition
Sites / Locations
- The Lady Davis Carmel Medical CenterRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Pneumoperitoneum
Arm Description
Patients undergoing laparoscopic surgery
Outcomes
Primary Outcome Measures
Cardiac output/cardiac index
Cardiac output/cardiac index will be measured before applying of pneumoperitoneum, 2-5 min after applying of pneumoperitoneum with intraabdominal pressure of 15 mmHg and 2-5 min after decrease of intraabdominal pressure until 10 mmHg
Secondary Outcome Measures
Systolic pressure variation (SPV)/Pulse pressure variation (PPV)
Systolic pressure variation/Pulse pressure variation will be measured before applying of pneumoperitoneum, 2-5 min after applying of pneumoperitoneum with intraabdominal pressure of 15 mmHg and 2-5 min after decrease of intraabdominal pressure until 10 mmHg
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01867814
Brief Title
Arterial and Plethysmographic Waveforms Variables as Predictors of Hemodynamic Response to Pneumoperitoneum
Acronym
SPV-PnP
Official Title
Clinical Trial for Evaluation of Arterial and Plethysmographic Waveform Variations as Predictors of Hemodynamic Response to Pneumoperitoneum During Laparoscopic Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
August 2015
Overall Recruitment Status
Unknown status
Study Start Date
May 2013 (undefined)
Primary Completion Date
November 2016 (Anticipated)
Study Completion Date
November 2016 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Carmel Medical Center
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Laparoscopic surgery is frequently associated with hemodynamic changes due to pneumoperitoneum (PnP). Those complex hemodynamic changes are difficult to predict and occasionally they require active therapeutic interventions or even interruption of the surgical procedure.
One of the main hemodynamic effects of PnP is a decrease in cardiac output due to reduction of venous return and cardiac preload. Although it has been shown repeatedly that waveform variables are good predictors of cardiac output response to volume loading, the prediction hemodynamic response to decrease of preload is more complex.
The investigators hypothesize that waveform variables will predict cardiac output changes resulting from PnP. Particularly, augmented values of waveform variables before PnP will be associated with a larger decrease of cardiac output after establishing PnP.
Detailed Description
Goals of the study
To evaluate hemodynamic changes caused by pneumoperitoneum applied for laparoscopic surgery
Endpoints
Blood Pressure: Systolic, Diastolic, Mean (SBP, DBP, MBP)
Heart Rate (HR)
Cardiac Output/Index (CO/CI)
Stroke Volume/Index (SV/SVI)
Systolic Pressure Variation (SPV)
Stroke Volume Variation (SVV)
Plethysmographic Waveform Variation (PWV)
Inclusion criteria
The patients scheduled for elective laparoscopic partial hepatectomy, laparoscopic splenectomy, laparoscopic pancreatectomy - required of continuous direct blood pressure monitoring according to the type of surgery
The patients ASA (American Society of Anesthesiologists)class III-IV scheduled for elective laparoscopic colectomy and hemicolectomy - required of continuous direct blood pressure monitoring according to their medical condition
Pneumoperitoneum by needle application only
Normal sinus cardiac rhythm
Exclusion criteria
Patients that didn't sign informed consent
Patients ASA class I-II scheduled for elective laparoscopic colectomy or hemicolectomy
Patients scheduled for elective laparoscopic cholecystectomy
Patients required of monitoring by pulmonary artery catheter during the surgery according to their medical condition
Study course, measurements and analysis
All study participants will get an explanation and sign on informed consent at least one day prior to the day of surgery
All study participants will receive standard anesthesia care. All patients will anesthetized intravenously with Fentanyl 2-5 mcg/kg, Propofol 1-2 mg/kg and Rocuronium 0.6-1.0 mg/kg followed by endotracheal intubation. Positive pressure ventilation with tidal volume 8 mL/kg of ideal body weight and respiratory rate 8-12 bpm to achieve end-tidal carbon dioxide of 33-37 mmHg will be applied after intubation. Anesthesia will be maintained with inhalation of Isoflurane (end-expiratory concentration at least 1.2%) in air/O2 (FiO2=0.4). Intraoperative fluid management will include an initial bolus of crystalloid solution (lactated Ringer's solution) at a dose of 7 mL/kg. Arterial blood pressure will be measured continuously through a radial arterial catheter. Pulse oximetry photoplethysmography will be monitored by index finger probe on the same side. Cardiac output will monitored noninvasively by NICOM (Non-invasive cardiac output monitor) that calculates stroke volume variation (SVV) in addition to cardiac output/cardiac index and stroke volume/stroke index
The study procedure will begin after induction of anesthesia, preparation of the patient for surgery and insertion of the pneumoperitoneum insufflation device. The study procedure will last for 10-15 minutes and will be finished before actual intraperitoneal surgical manipulation begins
Waveforms will be recorded from the patient monitor and values of NICOM will be noted at baseline before surgical manipulation, at PnP pressure=0 mmHg before gas insufflation but after insertion of peritoneal needle, and after PnP pressure reaches 15 mmHg (routine value for laparoscopic surgery). If after reaching PnP pressure of 15 mmHg CO will decrease by more than 20%, the PnP pressure will be reduced to 10 mmHg and recording of waveforms will be repeated after two minutes
Standard hemodynamic parameters (heart rate, systolic and diastolic BP) and waveform variables (SPV, PWV) will be measured and calculated offline according to the records
Parameters measured by NICOM (CO, CI, SV, SVI, SVV) will be noted at baseline (PnP pressure=0 mmHg), after PnP pressure reached 15 mmHg and after PnP pressure decreased till 10 mmHg (if necessary)
There will be no further follow up of the patients
We anticipate that there will be a significant number of patients with a reduction of CO by 20% or more after establishment of PnP of 15 mm Hg. We will perform comparisons between waveforms at baseline between those who decrease CO and those who do not. If there will be significant difference in variables at baseline there will be justification to perform ROC analysis to evaluate sensitivity and specificity of these variables to predict decrease in CO. In patients who will have a decrease in CO after PnP of 15 mm Hg we will compare the same variables to those that will be reached at PnP of 10 mmHg. These comparisons can help to understand the mechanisms of CO decrease during PnP
All of the analysis of the data will be performed after removing all identifying data
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pneumoperitoneum, Heart Output Disorder
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
150 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Pneumoperitoneum
Arm Type
Experimental
Arm Description
Patients undergoing laparoscopic surgery
Intervention Type
Procedure
Intervention Name(s)
Pneumoperitoneum
Intervention Description
Pneumoperitoneum 15 mmHg and 10 mmHg
Primary Outcome Measure Information:
Title
Cardiac output/cardiac index
Description
Cardiac output/cardiac index will be measured before applying of pneumoperitoneum, 2-5 min after applying of pneumoperitoneum with intraabdominal pressure of 15 mmHg and 2-5 min after decrease of intraabdominal pressure until 10 mmHg
Time Frame
Change of intraabdominal pressure before and 2-5 min after pneumoperitoneum
Secondary Outcome Measure Information:
Title
Systolic pressure variation (SPV)/Pulse pressure variation (PPV)
Description
Systolic pressure variation/Pulse pressure variation will be measured before applying of pneumoperitoneum, 2-5 min after applying of pneumoperitoneum with intraabdominal pressure of 15 mmHg and 2-5 min after decrease of intraabdominal pressure until 10 mmHg
Time Frame
Change of intraabdominal pressure before and 2-5 min after pneumoperitoneum
Other Pre-specified Outcome Measures:
Title
Plethysmographic Waveform Variation (PWV)
Description
Plethysmographic Waveform Variation will be measured before applying of pneumoperitoneum, 2-5 min after applying of pneumoperitoneum with intraabdominal pressure of 15 mmHg and 2-5 min after decrease of intraabdominal pressure until 10 mmHg
Time Frame
Change of intraabdominal pressure before and 2-5 min after pneumoperitoneum
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
The patients scheduled for elective laparoscopic partial hepatectomy, laparoscopic splenectomy, laparoscopic pancreatectomy - required of continuous direct blood pressure monitoring according to the type of surgery
The patients ASA class III-IV scheduled for elective laparoscopic colectomy and hemicolectomy - required of continuous direct blood pressure monitoring according to their medical condition
Pneumoperitoneum by needle application only
Normal sinus cardiac rhythm
Exclusion Criteria:
Patients that didn't sign informed consent
Patients ASA class I-II scheduled for elective laparoscopic colectomy or hemicolectomy
Patients scheduled for elective laparoscopic cholecystectomy
Patients required of monitoring by pulmonary artery catheter during the surgery according to their medical condition
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Reuven Pizov, MD
Phone
97248250625
Email
pizov_reuven@clalit.org.il
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pizov Reuven, MD
Organizational Affiliation
Carmel Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Lady Davis Carmel Medical Center
City
Haifa
ZIP/Postal Code
34362
Country
Israel
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Reuven Pizov, MD
Phone
97248250625
Email
pizov_reuven@clalit.org.il
First Name & Middle Initial & Last Name & Degree
Reuven Pizov, MD
12. IPD Sharing Statement
Learn more about this trial
Arterial and Plethysmographic Waveforms Variables as Predictors of Hemodynamic Response to Pneumoperitoneum
We'll reach out to this number within 24 hrs